08.04.2020
Left atrial appendage closure: a balanced management of the thromboembolic risk in patients with hemophilia and atrial fibrillation
verfasst von:
Marco Toselli, Davide Bosi, Giorgio Benatti, Emilia Solinas, Maria Alberta Cattabiani, Luigi Vignali
Erschienen in:
Journal of Thrombosis and Thrombolysis
|
Ausgabe 3/2020
Einloggen, um Zugang zu erhalten
Abstract
Atrial fibrillation is the most common cardiac arrhythmia and is a major cause of embolic stroke. In patients at high bleeding risk such as those with hemophilia, the thromboembolic prevention is challenging. We herein present three patients affected by moderate to severe hemophilia and atrial fibrillation that were treated in our Institution between March 2018 and September 2019, with percutaneous left atrial appendage closure. In patients with relative or absolute contraindications to long-term anticoagulant therapy, the left atrial appendage closure could represent a reasonable strategy.